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Growth hormone (GH) is a single-chain protein hormone of  about 190 residues, 
expressed mainly in the vertebrate anterior pituitary gland, which regulates somatic 
growth and various aspects of metabolism; many of these actions are mediated by 
insulin-like growth factor 1 (IGF1). Growth defects in humans frequently result from 
GH deficiency and are often treatable by GH administration. The evolution of GH 
illustrates many features of molecular evolution, including (i) the development and 
elaboration of gene/protein families by gene duplication, (ii) subtle changes resulting 
from incorporation of point mutations, which often occur during episodes of 
accelerated change, and (iii) co-evolution of hormones and their receptors. 
 
GH is structurally related to another pituitary hormone, prolactin, which in mammals 
regulates mammary growth and lactation and in lower vertebrates exhibits a wide 
range of activities, many relating to secondary aspects of reproduction.  Neither GH 
nor prolactin has been convincingly shown to occur in invertebrates.  The biological 
actions of GH and prolactin show considerable species specificity, as do their primary 
structures and gene organization, though linking biological and molecular variation is 
often difficult1. 
 
Gene duplication in the evolution of GH and prolactin 
 
GH and prolactin are structurally similar proteins at both the sequence level (about 
25% sequence identity) and at the level of 3-dimensional structure (both are 4-helix 
bundles with an unusual "up-up-down-down" topology - Figure 1). They are also 
encoded by similar genes, each with 5 exons and 4 introns, although the prolactin 
gene is larger (~10kb) than that of GH (~2 kb).  The two genes are found on different 
	   3	  
chromosomes in man, but clearly arose as a result of gene duplication followed by 
divergent evolution. The duplication probably occurred early in vertebrate evolution -  
GH and prolactin are distinct hormones in all but the most primitive vertebrates, the 
cyclostomes.  A related protein, somatolactin, is found in many fish, with about equal 
identity to GH and prolactin, presumably reflecting an additional gene duplication. 
 
A number of proteins, including erythropoietin and many interleukins, are distantly 
related to GH and prolactin and comprise a cytokine protein superfamily. Their 
structures all show the unusual up-up-down-down 4-helix bundle found in GH and 
prolactin (Figure 1), and their receptors also show similarity, with a single 
transmembrane domain and some conserved motifs.  This cytokine family probably 
arose as a consequence of gene duplications that occurred much earlier than that 
giving rise to GH and prolactin, before or soon after the origin of vertebrates. The 
period of divergent evolution that followed led to the loss of most sequence similarity 
between the cytokines, though the characteristic 3D fold was retained (3D structure is 
usually more conserved than sequence). 
 
More-recent duplications of prolactin and GH genes occurred during mammalian and 
avian evolution.  In passerine birds, duplication of the GH gene, was followed by 
rapid evolution2. Both genes are expressed in zebra finch brain, but their functions are 
not clear. In mammals the gene duplications have given rise to families of proteins 
expressed mainly in the placenta.  In ruminant artiodactyls and in rodents, 
independently, repeated duplications of the prolactin gene gave rise to up to 20 
closely-linked genes.  The protein products include placental lactogens (PLs) but their 
functions remain incompletely understood.  
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Higher primates also have a comparable cluster of genes expressed in the placenta, 
but these derive from multiple duplications of the GH gene.  In human five GH-like 
genes are clustered on chromosome 173 (Figure 2). The GH-N gene encodes pituitary 
GH, while the other genes are expressed in the placenta. Two genes (PL-A and PL-B) 
encode identical sequences for PL, about 85% identical to GH-N, expressed at high 
levels during pregnancy. PL-L (placental lactogen-like) encodes an abnormally 
spliced mRNA and may be a functionless pseudogene. GH-V encodes a GH variant, 
about 93% identical to GH-N, which is expressed in the placenta at moderate levels, 
apparently taking over from pituitary GH during pregnancy. Human GH is much 
more similar to the human PL than to non-primate GHs, and phylogenetic analysis 
confirms that the gene duplications that gave rise to this gene cluster occurred during 
the course of primate evolution. The role of human PL is not fully established. 
Experimentally they have lactogenic activity and relatively low growth-promoting 
activity, but they disappear from the circulation soon after parturition, at the time 
when lactogenesis increases. In some rare cases parturition and subsequent lactation 
are normal despite lack of PL genes and circulating PL.  PLs may play a role in 
regulating the metabolic balance between mother and foetus when nutritional 
resources are limited.  Maintaining this balance could involve maternal-foetal 
competition - the PL and GH-V genes are expressed on the foetal side of the placenta.  
 
Investigation of GH-related genes in other primates has thrown light on the evolution of 
this gene cluster.  In lower primates (including slow loris and bushbaby) there is a single 
GH gene, as in most non-primate mammals. Monkeys and apes have a cluster of GH-
related genes, as in man (Figure 2)4-6.  Remarkably, the GH-gene clusters found in Old 
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World Monkeys (OWM)/apes and New World Monkeys (NWM) (Figure 2) have arisen 
independently1,4,7. Each of these clusters contains several genes, at least some of which 
are expressed in the placenta, but their separate origins are shown by phylogenetic 
analysis, distribution of repetitive elements (Alu), and identification of "break-points" 
for the initial duplications. In one NWM, the capuchin, Cebus albifrons, the cluster 
comprises at least 40 GH-like genes and (mostly) pseudogenes4 - gene duplication 
seems to have run amok.  The evolutionary forces that led to independent duplications 
of the GH gene in both OWM/apes and NWM are not clear, but it is notable that they 
followed a period of rapid evolution of GH (see next section). 
 
Episodic evolution of GH 
 
A conventional view of molecular evolution holds that for any given protein the rate 
of evolution is rather constant, but that rates for different proteins vary considerably.  
In contrast, GH evolution shows a pattern in which slow, apparently rather constant, 
evolutionary change (near stasis) is interrupted by short episodes during which the 
rate of evolution increased 10-100-fold.  This episodic evolution is seen for amino 
acid changes/nonsynonymous nucleotide substitutions but not for synonymous 
substitutions which do not affect protein structure (Figure 3).  This and other evidence 
suggests that, in  some cases at least, the accelerated evolution was adaptive and 
associated with subtle changes in biological activity. 
 
A marked episode of accelerated GH evolution occurred on the lineage leading to 
higher primates, giving a substantial sequence difference (at about 35% of all 
residues) between human GH and GHs of non-primate mammals.  This explains why 
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non-primate GHs are not active in man so that, before recombinant DNA-derived 
human GH became available, human GH deficiency had to be treated with GH 
extracted from human pituitary glands collected post-mortem. The specific changes in 
both GH and its receptor that underlie the specificity arising during this burst of rapid 
change have been identified8, though changes in species specificity cannot themselves 
underlie the adaptive changes driving the accelerated evolution.  A possible 
mechanism explaining the episode of rapid evolution is "function switching",  in 
which a protein has two or more  biological actions, the relative importance of which 
varies over the course of evolutionary time1.  Repeated alternating adaptation of the 
hormone to performance of each of the functions would lead to accumulation of many 
amino acid substitutions with rather little overall change in biological activity. The 
pressure for rapid change could stop following the gene duplication, with one of the 
duplicate genes retaining one function of the hormone and the second adopting the 
other(s). A relevant second function for GH could have involved  placental 
expression, which may have had an early origin in primate evolution6.  Notably, the 
episode of rapid evolution preceded the gene duplications that gave rise to GH-gene 
clusters in OWM/apes and NWM (see above), and after gene duplication the rate of 
evolution of GH decreased. This, and the observation that the burst of rapid change is 
seen for nonsynonymous substitutions/amino acid changes in mature GH, but is much 
less marked for synonymous substitutions (Figure 3), or changes in signal peptides, 5' 
sequences or introns, supports the view that the changes during the accelerated 
evolution were adaptive in nature. 
 
Further episodes of rapid GH evolution are seen on several other mammalian 
lineages9, including the branch leading to ruminant artiodactyls (Figure 3). Among 
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lower vertebrates the rate of evolution is again generally slow (remarkably, the 
sequence of GH from a non-primate mammal such as pig is more similar to that of a 
shark than to human GH).  However, rates of evolution of teleost GHs are variable, 
and in some cases very high. 
 
Coevolution of GH, prolactin and their receptors 
 
Like all polypeptide hormones, GH and prolactin act by binding to receptors on the 
plasma membranes of their target cells.  The similarity between the two hormones is 
reflected in a corresponding similarity between the receptors. Presumably the gene 
duplication followed by divergence that gave rise to GH and prolactin was paralleled 
by a corresponding duplication and divergence giving rise to their receptors.  As a 
consequence there is some overlap in the receptor-binding and biological actions of 
the hormones - for example, in some species, including human, GH has quite high 
lactogenic activity. Such overlap suggests the possibility of coevolution of GH and 
prolactin, and the episodic evolution of the hormones at least partly accords with this. 
Like GH, prolactin evolution in mammals shows an episodic pattern and in some 
cases bursts of rapid evolution of prolactin coincide with those seen for GH (e.g. on 
lines leading to higher primates and ruminants), though in other cases there is no such 
coincidence10. 
 
Coevolution is also seen between GH and prolactin and their corresponding receptors.  
Thus, the episode of rapid change of GH during primate evolution is accompanied by 
a corresponding burst of evolution of the GH receptor.  The changes in the receptor 
are largely confined to the extracellular domain (the region that interacts with the 
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hormone) and, for both hormone and receptor, residues close to the hormone-receptor 
binding site are particularly involved (Figure 4).  On the other hand, for the 
accelerated evolution of GH seen on the lineage leading to armadillo (Figure 3), most 
changes occurred on the side of the hormone distant from the receptor-binding site 
(Figure 4), suggesting interaction of the hormone-receptor complex with one or more 
additional proteins9.  
 
Conclusion: tempo and mode in the evolution of protein hormones 
 
The evolution of GH displays an unusual pattern of molecular evolution.  For much of 
evolutionary time the hormone has been strongly conserved - a state of near stasis. 
But for brief periods rapid molecular change occurred, with change in the sequence of 
the hormone and/or the number of genes. During most of GH evolution in mammals 
(80-90%) the condition of near-stasis applied, but most of the evolutionary change 
(60-70%) occurred during short bursts corresponding to 10-20% of evolutionary time. 
In some cases the episodes of rapid change coincide with those seen for prolactin 
and/or the GH receptor, suggesting coevolution.  
 
Such a pattern disagrees with general expectation, and attempts have been made to 
explain it in part as reflecting GH gene gain and loss on various lineages6. Such an 
explanation seems unnecessarily complicated, particularly since detailed scrutiny of 
mammalian genomes provides no indication of such gain and loss, and the discovery 
of additional lineages showing apparent accelerated evolution of GH within 
mammals9 would imply additional undetected gain and loss. In those cases where 
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duplications of the GH or prolactin gene have occurred, they have followed 
accelerated evolution rather than preceded it. 
 
Is this pattern of bursts of rapid change occurring within an overall near-stasis 
confined to GH, or might it apply more generally?  Scrutiny of other protein 
hormones from a fairly limited number of mammalian species suggested that about 
half of them showed an episodic pattern of this sort10, including insulin, the common 
alpha-subunit of the glycoprotein hormones, and the beta-subunit of luteinizing 
hormone.  A similar pattern is seen in several other proteins, including haemoglobin 
and cytochrome c.  Although it was at one time thought that most evolutionary change 
in proteins was neutral in nature, it now seems likely that a substantial proportion of 
such change - perhaps 50% - is adaptive. It may be that a large proportion of this 
adaptive change occurs in episodes of accelerated evolution. 
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FIGURE LEGENDS 
 
Figure 1.  Structures of human GH (a) and Prolactin (b). Like other members of  
the cytokine superfamily the structure of these hormones is dominated by a 4-helix 
bundle; the conformation of this (up-up-down-down) differs from that seen in most 4-
helix bundle proteins (up-down-up-down) as illustrated in (c). Structural 
representations were constructed using PyMol and pdb entries 3hhr chain A (GH) and 
1RW5 (prolactin). 
 
Figure 2. The organization of GH gene clusters in primates.  In prosimians such as 
the slow loris, as in most non-primate mammals, there is a single GH-like gene, 
expressed in the pituitary gland. In higher primates there is a complex cluster of GH-
like genes, with pituitary-expressed GH at the 5' end followed by several placentally 
expressed genes (including those for placental lactogens, PLs). The clusters arose by 
sequential tandem duplications, apparently independently in New World monkeys and 
Old World monkeys/apes. Many of the clusters include one or more non-functional 
pseudogenes.  
 
Figure 3. Evolutionary trees for mammalian GHs. Trees were derived from coding 
sequences for mature GHs from representative species, using the codeml programme. 
Separate trees are shown, based on non-synonymous substitutions (A, essentially 
equivalent to amino acid sequences) and synonymous substitutions (B). In A, 
evolutionary rate is markedly variable, with episodes of rapid change occurring on the 
branches marked with thick lines; this contrasts with the much less variable 
evolutionary rates seen in B.  Evolutionary time is represented on the abscissa. 
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Numbers on branches are numbers of substitutions; the approximate times of 
duplications that gave rise to the GH-related placental proteins in NWM and OWM 
are shown by u.	  	  	  
Figure 4. Binding of GH to the extracellular domain of its receptor.  GH is shown 
in space-filling format (blue and yellow), while the two chains of the receptor are 
shown in line format (purple). For each model three views  are given, (a) sideways on 
(membrane at the bottom), (b) from the top and (c) from the bottom (looking up from 
the membrane). Residues which changed during the episodes of accelerated change 
occurring in the evolution of armadillo GH and human GH (Figure 3) are shown in 
yellow. For armadillo GH (top) most of the substitutions occurred in the region of the 
molecule away from the receptor. In human GH (bottom) most substitutions occurred 
on the side close to the membrane, with a substantial proportion (~30%) within 5A of 
the receptor-binding site. The difference is statistically significant. Constructed using 
PyMOL and pdb entry 3hhr (human GH bound to the extracellular domain of its 
receptor). 
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Fig. 3 
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